Skip to main content

Polaris Partners — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

186
Companies
$8.6B
Total invested
$56.5M
Avg. check
42
Industries
Health Care 14Biotechnology 12Therapeutics 7Medical 5Artificial Intelligence (AI) 5Big Data 4+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145168 of 186
AgBiome
September 2021

AgBiome discovers and develops innovative biological and trait products for crop protection.

Agriculture · Raleigh$116.0M Series D
OM1
July 2021

OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.

Big Data · Boston$85.0M Series D
Nifty
July 2021

Nifty's is a non-fungible token-focused social media platform.

Computer · MiamiConvertible Note
Montis Biosciences
June 2021

Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.

Biotechnology · Meise$1.2M Grant
Akili Interactive Labs
May 2021

Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.

Biotechnology · Boston$110.0M Series D
Hummingbird Bioscience
May 2021

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

Biotechnology · Woodlands$125.0M Series C
Dyno Therapeutics
May 2021

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

Artificial Intelligence (AI) · Cambridge$100.0M Series A
IconOVir Bio
January 2021

IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer.

Biotechnology · New York$77.0M Series A
Profitero
April 2020

Profitero is the eCommerce performance analytics platform of choice for leading brands around the world.

Analytics · Dún Laoghaire$20.0M Series B
Iora Health
February 2020

Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.

Health Care · Boston$126.0M Series F
Metacrine
September 2019

Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.

Biotechnology · San Diego$50.0M Debt Financing
Sofregen Medical
September 2019

Sofregen Medical is committed to developing innovative transformative solutions

Health Care · Cambridge$8.1M Series Unknown
NDVR
August 2019

NDVR is a wealth optimization company.

Finance · Boston$18.0M Series A
Ajax Health
June 2019

Ajax Health accelerates medical innovation through capital and capabilities.

Clinical Trials · Menlo Park$15.0M Series C
BlackThorn Therapeutics
June 2019

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Artificial Intelligence (AI) · San Francisco$76.0M Series B
KenSci
February 2019

KenSci offers Healthcare AI platfrom & prediction apps that work across Clinical workflows, Cost Mgmt & Hospital Ops. #DeathVsDataScience.

Analytics · Seattle$22.0M Series B
Quentis Therapeutics
December 2018

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.

Biotechnology · New York$1.0M Grant
Genuity Science
November 2018

Genuity Science is a biotechnology company that offers clinco-omics data analysis solutions for researchers.

Analytics · Boston$200.0M Series C
KSQ Therapeutics
September 2018

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

Biopharma · Cambridge$80.0M Series C
Space Monkey
August 2018

Space Monkey provides a subscription-based data storage solution enabling users to store data from any device.

Cloud Computing · Midvale$2.3M Series Unknown
Genomics Medicine Ireland
October 2016

Genomics Medicine Ireland is an Irish life sciences company conducting a study across Ireland of the human genome.

Biotechnology · Dublin$40.0M Series A
Spindle
June 2016

Spindle is a geo-restricted mobile app that provides information and updates on public events and places shared in Facebook and Twitter.

Events · Boston$1.2M Series Unknown
Ella Health
February 2016

Ella Health provides 3D mammography and physical therapy services specifically for women in a spa-like setting.

3D Technology · San Francisco$1.5M Series Unknown
Boxever
January 2016

Boxever is a digital optimization platform that uses data and AI to help brands make every customer interaction smarter.

Analytics · Dublin$12.0M Series B

Where Polaris Partners invests

Health Care14
Biotechnology12
Therapeutics7
Medical5
Artificial Intelligence (AI)5
Big Data4

About Polaris Partners's portfolio

How many companies has Polaris Partners invested in?

Polaris Partners has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Polaris Partners invest in?

Polaris Partners's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 42 different industry categories.

What is Polaris Partners's largest investment?

Among tracked funding rounds, Genuity Science received $200.0M in a Series C round. Polaris Partners's total known invested capital is $8.6B.

What is the average investment size for Polaris Partners?

Polaris Partners's average investment size is $56.5M across its portfolio of 186 companies.

What are Polaris Partners's most recent investments?

Recent Polaris Partners portfolio additions include AgBiome, OM1, Nifty, Montis Biosciences, Akili Interactive Labs. These companies were founded in 2020 or later.

Reach the founders behind these 186 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →